Envista Holdings Corp (STU:0HV)
€ 21 0 (0%) Market Cap: 3.63 Bil Enterprise Value: 4.18 Bil PE Ratio: 0 PB Ratio: 1.25 GF Score: 73/100

Envista Holdings Corp at Goldman Sachs Healthcare CEOs Unscripted Conference: A View from the Top (Virtual) Transcript

Jan 06, 2022 / 07:00PM GMT
Release Date Price: €39.3 (-0.35%)
Nathan Allen Rich
Goldman Sachs Group, Inc., Research Division - Research Analyst

Good afternoon, everyone, and thank you for joining for our next session. My name is Nathan Rich, and I cover the dental space here at Goldman Sachs. We're very pleased to welcome Envista, the second largest dental manufacturer globally to our CEOs unscripted conference today. We're joined by the company's CEO, Amir Aghdaei.

Amir, thank you so much for joining us. We really appreciate your time this afternoon. Before we get started, I'd just like to remind the audience that if you would like to submit a question, you can do so through the webcast or by e-mailing me at [email protected].

Questions & Answers

Nathan Allen Rich
Goldman Sachs Group, Inc., Research Division - Research Analyst

Amir, definitely a busy end of the year for the company with the acquisition of Carestream's intra-oral scanner business. You finally got the FDA approval of the N1 implant system, completed the KaVo divestiture early in the year here. Maybe to start with the Carestream deal,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot